Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) |
Prostatic Cancer, Castration-Resistant | Phase2 | Australia Austria Canada Czechia France Germany Israel Italy Netherlands Singapore South Korea Spain Taiwan United States View all |
NCT07047118 |
A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease |
Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD) | Phase1, Phase2 | France Germany Singapore Spain View all |
NCT07048197 |
An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis |
Rheumatoid Arthritis | Phase1 | Argentina Bulgaria China Germany Netherlands Romania Spain View all |
NCT07029555 |
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia |
Atherosclerotic Cardiovascular Disease | Russia | NCT06858332 | |
Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study |
Atherosclerotic Vascular Disease, Heterozygous Familial Hypercholesterolemia | Spain | NCT06958315 | |
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD |
Atherosclerotic Cardiovascular Disease (ASCVD) | Phase3 | China Hong Kong Puerto Rico Taiwan United Kingdom United States View all |
NCT06813911 |
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib |
Hematologic Malignancy, Solid Tumor, Advanced Malignancies | Phase3 | Belgium Italy Netherlands United Kingdom United States View all |
NCT06401356 |
Home Reported Outcomes in C3G Study |
C3 Glomerulopathy | United States | NCT07029542 | |
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
Metastatic Hormone-sensitive Prostate Cancer | Phase2 | Australia Czechia France Germany Italy Netherlands Poland Singapore South Korea Spain Taiwan United States View all |
NCT06991556 |
Post Marketing Study on Pluvicto in Korea |
Metastatic Castration-resistant Prostate Cancer | South Korea | NCT06514521 |